U.S. Markets close in 1 hr 43 mins
  • S&P 500

    4,416.11
    +4.32 (+0.10%)
     
  • Dow 30

    35,113.62
    +52.07 (+0.15%)
     
  • Nasdaq

    14,820.15
    -16.85 (-0.11%)
     
  • Russell 2000

    2,210.69
    +1.04 (+0.05%)
     
  • Crude Oil

    71.99
    -0.08 (-0.11%)
     
  • Gold

    1,797.50
    -4.30 (-0.24%)
     
  • Silver

    25.27
    +0.04 (+0.17%)
     
  • EUR/USD

    1.1812
    +0.0042 (+0.3544%)
     
  • 10-Yr Bond

    1.2710
    -0.0150 (-1.17%)
     
  • Vix

    18.09
    +0.89 (+5.17%)
     
  • GBP/USD

    1.3817
    +0.0063 (+0.4587%)
     
  • USD/JPY

    110.3240
    -0.1860 (-0.1683%)
     
  • BTC-USD

    39,415.83
    +4,980.61 (+14.46%)
     
  • CMC Crypto 200

    936.62
    +21.13 (+2.31%)
     
  • FTSE 100

    7,025.43
    -2.15 (-0.03%)
     
  • Nikkei 225

    27,833.29
    +285.29 (+1.04%)
     

S.Africa's Biovac to start making Pfizer-BioNTech vaccine in H2 2022 - CEO

In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

CAPE TOWN, July 21 (Reuters) - South Africa's Biovac Institute is aiming to start production of the mRNA COVID-19 vaccine developed by Pfizer and BioNTech in the second half of next year, its chief executive officer said on Wednesday.

Morena Makhoana told Reuters the Cape Town-based firm would ramp up production of the COVID-19 vaccine before reaching output of 100 million doses a year around early 2023. (Reporting by Wendell Roelf Editing by Alexander Winning)